Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease

Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease

Hepatitis C virus (HCV) is a leading cause of chronic liver disease, including chronic hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Hepatitis C infection associates with lipid and lipoprotein metabolism disorders such as hepatic steatosis, hypobetalipoproteinemia, and hypocholestero...

Full description

Bibliographic Details
Main Authors:	Thomas F. Baumert, Catherine Schuster, Mathieu Lefevre, Mohamed Lamine Hafirassou, Daniel J. Felmlee
Format:	Article
Language:	English
Published:	MDPI AG 2013-05-01
Series:	Viruses
Subjects:	Hepatitis C virus lipoproteins apolipoproteins apoE apoB cholesterol triglyceride viral attachment entry assembly secretion viral immune escape lipid disorder
Online Access:	http://www.mdpi.com/1999-4915/5/5/1292

Similar Items

Multiple functions of microsomal triglyceride transfer protein
by: Hussain M Mahmood, et al.
Published: (2012-02-01)

Assembly of very low density lipoproteins in mouse liver: evidence of heterogeneity of particle density in the Golgi apparatus
by: Larry L. Swift, et al.
Published: (2001-02-01)

Non-High-Density lipoprotein cholesterol or Apolipoprotein B in the prediction of myocardial infarction
by: Amit Kumar Pradhan, et al.
Published: (2017-04-01)

Sialic acid content of low density lipoprotein and its relation to lipid concentrations and metabolism of low density lipoprotein and cholesterol
by: Nina Lindbohm, et al.
Published: (2000-07-01)

Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma
by: Johan Björkegren, et al.
Published: (1998-07-01)

Human crypt intestinal epithelial cells are capable of lipid production, apolipoprotein synthesis, and lipoprotein assembly
by: Emile Levy, et al.
Published: (2000-01-01)

Effect of labeling of plasma lipoproteins with [3H]cholesterol on values of esterification rate of cholesterol in apolipoprotein B-depleted plasma
by: Milada Dobiášová, et al.
Published: (2000-08-01)

ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice
by: Emanuel Voyiaziakis, et al.
Published: (1998-02-01)

Known mutations of apoB account for only a small minority of hypobetalipoproteinemia
by: Jingshi Wu, et al.
Published: (1999-05-01)

Genetic and dietary effects on the physical properties, assembly and secretion of apoB-containing lipoproteins
by: Wang, Limin
Published: (2005)

Postprandial decrease in LDL-cholesterol in men with metabolic syndrome
by: Skoczyńska Anna, et al.
Published: (2015-02-01)

ASSOCIATION OF CAROTID INTIMA-MEDIA THICKNESS WITH LEPTIN AND APOLIPOPROTEIN B/APOLIPOPROTEIN A-I RATIO REVEALS IMMINENT PREDICTORS OF SUBCLINICAL ATHEROSCLEROSIS IN PSORIASIS PATIENTS
by: Kumari Asha, et al.
Published: (2014-01-01)

ApoB-100 Lipoprotein Complex Formation with Intima Proteoglycans as a Cause of Atherosclerosis and Its Possible Ex Vivo Evaluation as a Disease Biomarker
by: Eva Hurt-Camejo, et al.
Published: (2018-07-01)

Preferential clearance of apoB-48-containing lipoproteins after heparin-induced lipolysis is modulated by lipoprotein lipase activity1
by: André P. van Beek, et al.
Published: (1998-02-01)

Vasculoprotective properties of plasma lipoproteins from brown bears (Ursus arctos)
by: Matteo Pedrelli, et al.
Published: (2021-01-01)

Suppression of cytosolic triacylglycerol recruitment for very low density lipoprotein assembly by inactivation of microsomal triglyceride transfer protein results in a delayed removal of apoB-48 and apoB-100 from microsomal and Golgi membranes of primary rat hepatocytes
by: Abdel-Malek Hebbachi, et al.
Published: (1999-10-01)

ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator
by: Toshimi Kido, et al.
Published: (2017-11-01)

Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
by: Liliana Fonseca, et al.
Published: (2020-06-01)

Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity
by: G.F. Watts, et al.
Published: (2000-03-01)

Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B
by: Uwe J.F. Tietge, et al.
Published: (1999-11-01)

Lower plasma PCSK9 in normocholesterolemic subjects is associated with upregulated adipose tissue surface‐expression of LDLR and CD36 and NLRP3 inflammasome
by: Yannick Cyr, et al.
Published: (2021-02-01)

Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content
by: Christina Khoo, et al.
Published: (1999-02-01)

Régulation de l'apolipoprotéine C-I dans les cellules HepG2 et son rôle dans le métabolisme des lipides
by: Bouchard, Catherine
Published: (2016)

The N-linked oligosaccharides at the amino terminus of human apoB are important for the assembly and secretion of VLDL
by: Jelena Vukmirica, et al.
Published: (2002-09-01)

THE ROLE OF APOB-CONTAINING LIPOPROTEINS IN ABDOMINAL AORTIC ANEURYSM
by: Liu, Jing
Published: (2015)

An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis
by: Rosanne M. Crooke, et al.
Published: (2005-05-01)

Association of serum paraoxonase activity with lipid profile, APO-A and APO-B in subjects with different levels of HDL
by: Maryam Teimouri, et al.
Published: (2018-11-01)

Gene-Gene Interactions among Pparα/δ/γ Polymorphisms for Apolipoprotein (Apo) A-I/Apob Ratio in Chinese Han Population.
by: Bo Hai, et al.
Published: (2014-06-01)

The effect of Puerariae radix on lipoprotein metabolism in liver and intestinal cells
by: Ho Nerissa, et al.
Published: (2002-12-01)

Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro
by: Denise K. Bonen, et al.
Published: (1998-08-01)

Vaccination in Atherosclerosis
by: Felix Sebastian Nettersheim, et al.
Published: (2020-11-01)

Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins
by: Wanda Vélez-Carrasco, et al.
Published: (1999-09-01)

KINETIC STUDIES TO ELUCIDATE IMPAIRED METABOLISM OF TRIGLYCERIDE-RICH LIPOPROTEINS IN HUMANS
by: Martin eAdiels, et al.
Published: (2015-11-01)

Role of high-density lipoprotein cholesterol in health and diseases
by: Brijesh Yadav, et al.
Published: (2021-01-01)

Apolipoprotein E–low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner
by: Lance A. Johnson, et al.
Published: (2014-04-01)

ApoB et résistance à l'insuline : association avec l'activation du système IL-1β
by: Saint-Pierre, Nathalie
Published: (2014)

Rat McA-RH7777 cells efficiently assemble rat apolipoprotein B-48 or larger fragments into VLDL but not human apolipoprotein B of any size
by: Qunong Xiao, et al.
Published: (2000-01-01)

Protective Effects of Alisma orientale Extract against Hepatic Steatosis via Inhibition of Endoplasmic Reticulum Stress
by: Min-Kyung Jang, et al.
Published: (2015-11-01)

Variations in biomarkers of dyslipidemia and dysbiosis during the menstrual cycle: a pilot study in healthy volunteers
by: Helena Bergström, et al.
Published: (2021-04-01)

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
by: Jan Borén, et al.
Published: (2020-07-01)